Financials
Financial year 2025
ALMAPHARMA from De Panne, company number BE0427782965, closed financial year 2025 with a result of € 28,272 after tax. For that financial year ALMAPHARMA recorded a gross margin of € 223,954 and equity of € 256,263. Compared with financial year 2024, the result moved from € 44,586 to € 28,272. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 7, 2026.
€ 256,263
▲ 12% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 28,272
▼ 37% vs 2024
Profit after tax over the fiscal year.
€ 61,642
▲ 8% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 236,263.
People and assets in 2025
2.2
Average over the fiscal year, from the social balance sheet.
€ 160,902
▲ 4% vs 2024
€ 73,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,465
▼ 13% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 89,578
▲ 186% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 36,655
▼ 21% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 162,606 | € 253,762 | € 208,214 | € 223,954 | ▲ 8% |
| Profit after taxes | € 71,921 | € 82,829 | € 44,586 | € 28,272 | ▼ 37% |
| Equity | € 308,575 | € 251,404 | € 227,991 | € 256,263 | ▲ 12% |
| Total debts | € 134,772 | € 74,802 | € 150,926 | € 259,302 | ▲ 72% |
| Cash | € 81,132 | € 33,627 | € 56,971 | € 61,642 | ▲ 8% |
| Land & buildings | € 6,829 | € 5,297 | € 4,958 | € 108,895 | ▲ € 103,937 |
| Retained profit | € 288,575 | € 231,404 | € 207,991 | € 236,263 | ▲ 14% |
| Dividend | € 0 | € 140,000 | € 68,000 | € 0 | ▼ 100% |
| Balance sheet total | € 443,347 | € 326,206 | € 378,917 | € 515,565 | ▲ 36% |
| Employees (FTE) | 1 | 1.9 | 2.2 | 2.2 |
Key figures of ALMAPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to ALMAPHARMA?
What happened at ALMAPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 28,272 (▼ 37% vs 2024). Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in De Panne. KBO
In short
From € 71,921 profit in 2022 to € 28,272 profit in 2025.
Paid € 63,857 in corporate taxes since 2022.
Best year ever: 2023, with € 82,829 profit.
On average € 101,800 of value added per employee in 2025.
Management
Behind ALMAPHARMA is Lindammer CommV. Lindammer CommV is also behind Apotheek Omnia, ODEPHARMA and APOTHEEK SINT-IDESBALD.
Directors
According to the 2025 annual accounts
Director · represented by Marceau DECRU
Also active at: Apotheek Omnia, ODEPHARMA, APOTHEEK SINT-IDESBALD
Establishments
Establishment units
Physical locations of this company
De Pannelaan 15
8660 De Panne
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0427.782.965
- VAT number
- BE 0427.782.965
- Registered office
- De Pannelaan 15, 8660 De Panne
- Names & denominations
- ALMAPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 22 August 1985
- Peppol
- Active · Active since 24 Sept 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers